Loading...

OVID OVID THERAPEUTICS INC Other Situations 8-K Filing

VD T

VD

OVID THERAPEUTICS INC

(OVID)

2024 8-K

Show Summary

Show Summary

Asset Acquisitions

Financial Results

Board Appointment

Q3 2024 Results

Management Change

Q2 2024 Results

Departure of Directors

Annual Meeting Results

Earnings Reports

Financial Results

Earnings Reports

Earnings Reports

Annual Meeting Results

Earnings Reports

Collaboration and License A...

Financial Results Announcement

Regulation FD Disclosure

External Links:

Ovid Therapeutics Inc. issued a press release reporting on Takeda Pharmaceutical Company Limited's Announcement of Phase 3 topline study results for soticlestat.

AI Assistant

OVID THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.